Geoffrey Scott Spencer, MD
Gastroenterology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Offices
- 5
Offices
5 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: El Camino Health · Good Samaritan Hospital. That is not proof they admit you there this week.
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Spencer’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A108150 · Current
Licensed to practise in California · since 2009 · expires 2028-08-31 · Eastern Virginia Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Endoscopy Surgery Center of Silicon Valley, LLCAmbulatory Surgery Center · San Jose, CA7% owner since 2010 · accredited by AAAHCAccreditation Renewed2 inspections · last 2015-09-14
- Silicon Valley Surgery Center, LPAmbulatory Surgery Center · Campbell, CA2.09% owner since 2011 · accredited by AAAHCAccreditation Renewed4 inspections, 1 with deficiencies · last 2024-09-16
- Silicon Valley Surgery Center, LP - BascomAmbulatory Surgery Center · Campbell, CA2.09% owner since 2011 · accredited by AAAHCAccreditation RenewedNo inspections published
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$213,139
Medicare paid this office $213,139 for 874 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 286 | $68,396 | $239 |
| Biopsy of large bowel using a flexible endoscope | 450 | $42,191 | $94 |
| Return visit (30+ min) | 229 | $29,980 | $109 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 234 | $17,314 | $72 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 88 | $13,220 | $145 |
See all 11 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 286 | $68,396 | $239 |
| Biopsy of large bowel using a flexible endoscope | 450 | $42,191 | $94 |
| Return visit (30+ min) | 229 | $29,980 | $109 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 234 | $17,314 | $72 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 88 | $13,220 | $145 |
| New patient visit (45+ min) | 73 | $10,218 | $140 |
| Short return visit (20+ min) | 70 | $5,622 | $75 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 46 | $4,376 | $91 |
| Long return visit (40+ min) | 16 | $3,050 | $161 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 24 | $2,656 | $102 |
| New patient visit (30+ min) | 22 | $1,861 | $85 |
Procedures Medicare counted
| Colonoscopy | 106 | More than 81% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 247 | More than 93% of doctors who do this |
Who their Medicare patients are
874 Original Medicare patients in 2024. Average age 75 · Under 65 2% · 85 and older 9% · Women 54% · Also on Medicaid 6% · Health risk score 1.09. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 70% · Coronary heart disease 30% · Diabetes 24% · Cancer 19% · Atrial fibrillation 18% · Chronic kidney disease 17% · Depression 14% · Heart failure 12% · COPD 11% · Dementia 7% · Stroke 7%.
The office billed $2,268,295, Medicare allowed $270,752 and paid $213,139; for 1,696 services of 34 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 874 | 1,696 | 75 | 1.09 | $2,268,295 | $213,139 |
| 2023 | 902 | 1,771 | 75 | 1.06 | $2,254,552 | $228,646 |
| 2022 | 895 | 1,850 | 75 | 0.94 | $2,121,454 | $226,076 |
| 2021 | 862 | 1,883 | 75 | 1.04 | $2,002,734 | $232,294 |
| 2020 | 733 | 1,676 | 75 | 1.25 | $1,667,948 | $192,021 |
| 2019 | 839 | 2,227 | 75 | 1.10 | $2,091,178 | $223,620 |
| 2018 | 872 | 2,408 | 75 | 1.14 | $2,046,990 | $230,351 |
| 2017 | 618 | 1,728 | 74 | 1.21 | $1,383,806 | $163,093 |
| 2016 | 492 | 1,221 | 74 | 1.26 | $952,091 | $127,809 |
| 2015 | 469 | 1,297 | 75 | 1.34 | $878,590 | $146,505 |
| 2014 | 476 | 1,467 | 75 | 1.22 | $828,042 | $161,188 |
| 2013 | 462 | 1,631 | 75 | 1.43 | $784,353 | $175,204 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 291 | $71,462 | $246 |
| Biopsy of large bowel using a flexible endoscope | 514 | $52,634 | $102 |
| Return visit (30+ min) | 238 | $32,721 | $112 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 197 | $13,969 | $69 |
| New patient visit (45+ min) | 94 | $13,012 | $138 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 81 | $12,751 | $155 |
| Short return visit (20+ min) | 54 | $4,882 | $84 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 43 | $4,686 | $104 |
| Long return visit (40+ min) | 24 | $4,163 | $173 |
| New patient visit (30+ min) | 40 | $3,563 | $89 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 23 | $2,491 | $108 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $1,854 | $71 |
| Injection beneath lining of large bowel using a flexible endoscope | 11 | $170 | $15 |
2022: 14 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 270 | $63,861 | $235 |
| Biopsy of large bowel using a flexible endoscope | 490 | $46,476 | $94 |
| Return visit (30+ min) | 242 | $35,273 | $112 |
| New patient visit (45+ min) | 114 | $16,111 | $141 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 188 | $12,489 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 67 | $11,704 | $175 |
| New patient visit (30+ min) | 78 | $6,160 | $79 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 48 | $5,825 | $112 |
| Short return visit (20+ min) | 55 | $5,369 | $84 |
| Long return visit (40+ min) | 20 | $3,424 | $171 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 26 | $2,866 | $65 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 21 | $2,452 | $107 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,722 | $123 |
| Injection beneath lining of large bowel using a flexible endoscope | 13 | $195 | $15 |
2021: 14 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 227 | $54,580 | $237 |
| Biopsy of large bowel using a flexible endoscope | 436 | $45,315 | $103 |
| Return visit (30+ min) | 245 | $33,874 | $114 |
| New patient visit (45+ min) | 111 | $16,847 | $152 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 221 | $16,119 | $71 |
| New patient visit (30+ min) | 143 | $13,595 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 75 | $13,589 | $181 |
| Short return visit (20+ min) | 97 | $8,794 | $84 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 46 | $5,710 | $114 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 33 | $3,454 | $66 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 22 | $2,370 | $108 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,787 | $128 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 24 | $216 | $9 |
| Injection beneath lining of large bowel using a flexible endoscope | 13 | $193 | $15 |
2020: 17 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 214 | $51,824 | $241 |
| Biopsy of large bowel using a flexible endoscope | 343 | $29,552 | $86 |
| Return visit (30+ min) | 190 | $21,631 | $95 |
| New patient visit (45+ min) | 100 | $14,808 | $148 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 170 | $13,099 | $72 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 70 | $13,092 | $184 |
| New patient visit (30+ min) | 88 | $7,898 | $90 |
| Short return visit (20+ min) | 107 | $7,350 | $63 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 33 | $4,360 | $109 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 40 | $3,973 | $67 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 35 | $3,916 | $109 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 28 | $3,586 | $128 |
| Telephone medical discussion with physician, 21-30 minutes | 18 | $1,838 | $102 |
| Telephone medical discussion with physician, 11-20 minutes | 12 | $910 | $76 |
| Injection beneath lining of large bowel using a flexible endoscope | 13 | $374 | $29 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 47 | $232 | $5 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 14 | $126 | $9 |
2019: 17 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 299 | $71,459 | $237 |
| Biopsy of large bowel using a flexible endoscope | 416 | $30,914 | $74 |
| Return visit (30+ min) | 223 | $25,547 | $92 |
| New patient visit (45+ min) | 101 | $14,844 | $147 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 196 | $14,477 | $71 |
| New patient visit (30+ min) | 133 | $12,424 | $93 |
| Short return visit (20+ min) | 128 | $10,658 | $68 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 56 | $6,849 | $120 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 36 | $6,619 | $184 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 45 | $5,851 | $110 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 32 | $3,645 | $66 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 32 | $3,382 | $106 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 24 | $1,355 | $36 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 13 | $1,154 | $89 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 229 | $1,128 | $5 |
| Injection beneath lining of large bowel using a flexible endoscope | 18 | $276 | $15 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 22 | $189 | $9 |
2018: 18 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 288 | $67,995 | $234 |
| Return visit (30+ min) | 250 | $26,486 | $92 |
| Biopsy of large bowel using a flexible endoscope | 372 | $24,730 | $66 |
| New patient visit (45+ min) | 137 | $18,568 | $136 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 225 | $17,084 | $72 |
| New patient visit (30+ min) | 160 | $13,678 | $85 |
| Short return visit (20+ min) | 160 | $11,055 | $62 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 69 | $9,166 | $122 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $5,821 | $182 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 45 | $5,239 | $109 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 41 | $4,579 | $100 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 29 | $3,465 | $65 |
| Long return visit (40+ min) | 15 | $1,599 | $107 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 97 | $1,264 | $11 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 25 | $1,084 | $35 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 207 | $1,002 | $5 |
| Injection beneath lining of large bowel using a flexible endoscope | 21 | $323 | $15 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 23 | $204 | $9 |
2017: 17 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 174 | $39,250 | $226 |
| Biopsy of large bowel using a flexible endoscope | 240 | $20,506 | $84 |
| New patient visit (45+ min) | 123 | $16,686 | $136 |
| Return visit (30+ min) | 148 | $16,168 | $91 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 178 | $14,150 | $78 |
| New patient visit (30+ min) | 116 | $9,053 | $78 |
| Short return visit (20+ min) | 118 | $8,351 | $57 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 36 | $6,195 | $172 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 48 | $5,682 | $118 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 40 | $4,088 | $100 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 27 | $3,119 | $111 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 49 | $2,948 | $34 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $2,471 | $62 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 53 | $684 | $11 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 131 | $612 | $5 |
| Injection beneath lining of large bowel using a flexible endoscope | 16 | $566 | $35 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 18 | $162 | $9 |
2016: 13 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 91 | $22,003 | $237 |
| Biopsy of large bowel using a flexible endoscope | 169 | $17,846 | $104 |
| Return visit (30+ min) | 147 | $16,292 | $91 |
| New patient visit (45+ min) | 84 | $11,703 | $139 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 123 | $10,472 | $83 |
| New patient visit (30+ min) | 105 | $8,805 | $84 |
| Short return visit (20+ min) | 102 | $6,801 | $61 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 45 | $5,586 | $121 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $5,106 | $176 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 33 | $3,718 | $106 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 44 | $3,697 | $35 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 27 | $3,264 | $121 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $2,636 | $64 |
2015: 13 services
| Biopsy of large bowel using a flexible endoscope | 144 | $22,481 | $156 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 71 | $19,931 | $277 |
| New patient visit (45+ min) | 124 | $18,555 | $150 |
| Return visit (30+ min) | 111 | $14,091 | $97 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 122 | $11,858 | $89 |
| Short return visit (20+ min) | 142 | $11,503 | $66 |
| New patient visit (30+ min) | 83 | $8,478 | $102 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $6,914 | $68 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 43 | $5,697 | $127 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $4,698 | $188 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 54 | $3,863 | $36 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 18 | $3,641 | $121 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 33 | $3,551 | $108 |
2014: 15 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 104 | $27,070 | $260 |
| New patient visit (45+ min) | 150 | $20,858 | $139 |
| Biopsy of large bowel using a flexible endoscope | 166 | $20,030 | $121 |
| Return visit (30+ min) | 152 | $17,624 | $91 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 168 | $14,296 | $81 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 57 | $10,223 | $176 |
| Short return visit (20+ min) | 103 | $8,330 | $63 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 53 | $6,441 | $119 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 87 | $5,884 | $34 |
| New patient visit (30+ min) | 65 | $5,680 | $87 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 38 | $4,169 | $107 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 27 | $2,875 | $103 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $2,700 | $63 |
| New patient visit (60+ min) | 16 | $2,697 | $169 |
| Diagnostic exam of large bowel using a flexible endoscope | 13 | $2,438 | $188 |
2013: 16 services
| Return visit (30+ min) | 172 | $24,099 | $94 |
| Biopsy of large bowel using a flexible endoscope | 134 | $20,028 | $148 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 156 | $19,031 | $109 |
| New patient visit (45+ min) | 130 | $18,451 | $142 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 65 | $17,220 | $265 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 59 | $10,748 | $173 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 100 | $9,839 | $33 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 68 | $8,680 | $113 |
| Short return visit (20+ min) | 91 | $7,414 | $65 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 42 | $5,813 | $119 |
| New patient visit (30+ min) | 60 | $5,510 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 42 | $4,753 | $62 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 24 | $3,948 | $132 |
| New patient visit (60+ min) | 17 | $3,140 | $185 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $3,006 | $231 |
| Diagnostic exam of large bowel using a flexible endoscope | 16 | $2,930 | $183 |
Drugs they prescribed that Part D paid
$597,629
Pharmacies billed $597,629 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,219) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
977 generic and 242 brand-name prescriptions · $597,629 in drug cost · 46 antibiotic prescriptions to 28 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Stelara | 11 | $293,123 | $26,648 |
| Humira(Cf) | 14 | $95,361 | $6,812 |
| Creon | 11 | $32,456 | $2,951 |
| Mesalamine | 40 | $26,319 | $658 |
| Sod Sulf-Potass Sulf-Mag Sulf | 247 | $16,344 | $66 |
See all 17 drugs
| Stelara | 11 | $293,123 | $26,648 |
| Humira(Cf) | 14 | $95,361 | $6,812 |
| Creon | 11 | $32,456 | $2,951 |
| Mesalamine | 40 | $26,319 | $658 |
| Sod Sulf-Potass Sulf-Mag Sulf | 247 | $16,344 | $66 |
| Linzess | 11 | $11,774 | $1,070 |
| Dexlansoprazole Dr | 32 | $11,024 | $344 |
| Tenofovir Disoproxil | 15 | $6,342 | $423 |
| Mesalamine Er | 16 | $5,531 | $346 |
| Ursodiol | 26 | $4,722 | $182 |
| Peg 3350-Electrolyte | 172 | $3,352 | $19 |
| Omeprazole | 182 | $2,588 | $14 |
| Pantoprazole | 120 | $2,416 | $20 |
| Sulfasalazine | 25 | $790 | $32 |
| Famotidine | 63 | $549 | $9 |
| Esomeprazole Magnesium | 19 | $429 | $23 |
| Dicyclomine | 14 | $288 | $21 |
Year by year
| 2024 | 1,219 | 605 | 0% (0) | 20% | $597,629 |
| 2023 | 1,355 | 655 | 0% (0) | 25% | $780,639 |
| 2022 | 1,442 | 638 | 0% (0) | 34% | $730,416 |
| 2021 | 1,333 | 607 | 0% (0) | 43% | $656,794 |
| 2020 | 1,103 | 467 | 0% (0) | 34% | $335,438 |
| 2019 | 1,196 | 532 | 0% (0) | 41% | $328,943 |
| 2018 | 1,142 | 482 | None | 43% | $212,095 |
| 2017 | 757 | 315 | 0% (0) | None | $116,186 |
| 2016 | 595 | 227 | 0% (0) | 40% | $125,058 |
| 2015 | 659 | 199 | 0% (0) | None | $495,029 |
| 2014 | 683 | 192 | None | 25% | $57,671 |
| 2013 | 604 | 177 | 2% (12) | 30% | $49,447 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 19 drugs
| Stelara | 16 | $445,598 | $27,850 |
| Mesalamine | 28 | $22,080 | $789 |
| Linzess | 30 | $22,072 | $736 |
| Dexlansoprazole Dr | 35 | $14,795 | $423 |
| Sod Sulf-Potass Sulf-Mag Sulf | 177 | $13,660 | $77 |
| Mesalamine Er | 26 | $7,786 | $299 |
| Ursodiol | 38 | $6,589 | $173 |
| Peg 3350-Electrolyte | 248 | $5,262 | $21 |
| Dexilant | 16 | $4,972 | $311 |
| Suprep | 38 | $4,548 | $120 |
| Omeprazole | 207 | $2,747 | $13 |
| Pantoprazole | 142 | $2,360 | $17 |
| Tenofovir Disoproxil | 11 | $1,784 | $162 |
| Sulfasalazine | 25 | $1,149 | $46 |
| Lansoprazole | 14 | $1,098 | $78 |
| Budesonide Dr | 11 | $935 | $85 |
| Famotidine | 63 | $680 | $11 |
| Dicyclomine | 22 | $453 | $21 |
| Lactulose | 14 | $132 | $9 |
2022: 23 drugs
| Stelara | 13 | $336,604 | $25,893 |
| Creon | 21 | $51,850 | $2,469 |
| Xifaxan | 19 | $44,368 | $2,335 |
| Suprep | 187 | $21,701 | $116 |
| Dexilant | 39 | $20,553 | $527 |
| Linzess | 39 | $20,523 | $526 |
| Mesalamine | 22 | $18,537 | $843 |
| Mesalamine Er | 29 | $12,066 | $416 |
| Ursodiol | 24 | $4,716 | $197 |
| Omeprazole | 265 | $3,974 | $15 |
| Peg 3350-Electrolyte | 122 | $2,270 | $19 |
| Pantoprazole | 152 | $2,262 | $15 |
| Gavilyte-C | 96 | $1,543 | $16 |
| Budesonide Dr | 16 | $1,354 | $85 |
| Sulfasalazine | 24 | $1,238 | $52 |
| Famotidine | 81 | $1,226 | $15 |
| Balsalazide Disodium | 11 | $1,109 | $101 |
| Peg3350-Sod Sul-Nacl-Kcl-Asb-C | 11 | $787 | $72 |
| Gavilyte-G | 35 | $524 | $15 |
| Dicyclomine | 18 | $454 | $25 |
| Ondansetron | 19 | $285 | $15 |
| Lactulose | 13 | $278 | $21 |
| Peg-3350 and Electrolytes | 15 | $200 | $13 |
2021: 20 drugs
| Humira(Cf) | 14 | $144,132 | $10,295 |
| Xifaxan | 28 | $81,926 | $2,926 |
| Suprep | 253 | $28,069 | $111 |
| Mesalamine | 24 | $24,221 | $1,009 |
| Linzess | 34 | $22,058 | $649 |
| Creon | 12 | $21,065 | $1,755 |
| Mesalamine Er | 32 | $17,663 | $552 |
| Dexilant | 39 | $16,997 | $436 |
| Ursodiol | 21 | $5,017 | $239 |
| Omeprazole | 239 | $3,617 | $15 |
| Peg3350-Sod Sul-Nacl-Kcl-Asb-C | 34 | $3,154 | $93 |
| Pantoprazole | 133 | $2,808 | $21 |
| Clenpiq | 11 | $1,762 | $160 |
| Budesonide Dr | 12 | $1,319 | $110 |
| Sulfasalazine | 24 | $1,306 | $54 |
| Peg 3350-Electrolyte | 73 | $1,301 | $18 |
| Famotidine | 56 | $929 | $17 |
| Gavilyte-C | 55 | $777 | $14 |
| Peg-3350 and Electrolytes | 14 | $168 | $12 |
| Ondansetron | 12 | $126 | $10 |
2020: 16 drugs
| Humira(Cf) | 13 | $75,853 | $5,835 |
| Xifaxan | 22 | $54,003 | $2,455 |
| Mesalamine | 19 | $17,807 | $937 |
| Suprep | 159 | $16,665 | $105 |
| Mesalamine Er | 29 | $13,691 | $472 |
| Dexilant | 29 | $10,821 | $373 |
| Linzess | 15 | $10,565 | $704 |
| Ursodiol | 25 | $10,158 | $406 |
| Budesonide Ec | 19 | $4,459 | $235 |
| Omeprazole | 231 | $3,494 | $15 |
| Pantoprazole | 129 | $2,127 | $16 |
| Sulfasalazine | 17 | $1,303 | $77 |
| Peg 3350-Electrolyte | 72 | $1,074 | $15 |
| Gavilyte-N | 73 | $1,004 | $14 |
| Famotidine | 48 | $949 | $20 |
| Ondansetron | 13 | $135 | $10 |
2019: 18 drugs
| Xifaxan | 25 | $63,061 | $2,522 |
| Mesalamine | 23 | $25,200 | $1,096 |
| Suprep | 197 | $19,650 | $100 |
| Linzess | 25 | $18,783 | $751 |
| Apriso | 26 | $14,457 | $556 |
| Amitiza | 15 | $11,333 | $756 |
| Ursodiol | 17 | $6,064 | $357 |
| Dexilant | 12 | $5,847 | $487 |
| Budesonide Ec | 13 | $5,170 | $398 |
| Omeprazole | 242 | $3,886 | $16 |
| Pantoprazole | 150 | $1,982 | $13 |
| Moviprep | 18 | $1,932 | $107 |
| Peg 3350-Electrolyte | 97 | $1,710 | $18 |
| Esomeprazole Magnesium | 17 | $1,344 | $79 |
| Gavilyte-N | 88 | $1,190 | $14 |
| Sulfasalazine | 17 | $1,167 | $69 |
| Ranitidine | 33 | $1,004 | $30 |
| Sulfasalazine Dr | 12 | $959 | $80 |
2018: 20 drugs
| Xifaxan | 27 | $55,260 | $2,047 |
| Lialda | 18 | $35,154 | $1,953 |
| Suprep | 249 | $23,218 | $93 |
| Linzess | 23 | $14,076 | $612 |
| Amitiza | 21 | $12,279 | $585 |
| Apriso | 22 | $10,754 | $489 |
| Ursodiol | 20 | $8,770 | $439 |
| Budesonide Ec | 16 | $6,774 | $423 |
| Dexilant | 14 | $5,050 | $361 |
| Omeprazole | 232 | $3,199 | $14 |
| Pantoprazole | 154 | $1,795 | $12 |
| Azathioprine | 18 | $1,530 | $85 |
| Ranitidine | 50 | $1,287 | $26 |
| Nadolol | 17 | $1,277 | $75 |
| Sulfasalazine | 24 | $1,249 | $52 |
| Esomeprazole Magnesium | 14 | $1,237 | $88 |
| Sulfasalazine Dr | 11 | $1,181 | $107 |
| Moviprep | 11 | $1,097 | $100 |
| Peg 3350-Electrolyte | 48 | $835 | $17 |
| Gavilyte-N | 40 | $630 | $16 |
2017: 13 drugs
| Lialda | 22 | $29,448 | $1,339 |
| Suprep | 171 | $15,063 | $88 |
| Linzess | 25 | $9,466 | $379 |
| Amitiza | 25 | $9,152 | $366 |
| Flovent Hfa | 11 | $3,944 | $359 |
| Omeprazole | 126 | $1,777 | $14 |
| Ursodiol | 12 | $1,703 | $142 |
| Azathioprine | 23 | $1,382 | $60 |
| Pantoprazole | 88 | $828 | $9 |
| Peg 3350-Electrolyte | 31 | $419 | $14 |
| Ranitidine | 26 | $240 | $9 |
| Peg 3350-Electrolyte | 13 | $140 | $11 |
| Metoclopramide | 12 | $66 | $6 |
2016: 11 drugs
| Lialda | 13 | $13,964 | $1,074 |
| Linzess | 25 | $8,204 | $328 |
| Apriso | 16 | $6,632 | $415 |
| Moviprep | 52 | $4,542 | $87 |
| Flovent Hfa | 11 | $3,633 | $330 |
| Suprep | 31 | $2,594 | $84 |
| Omeprazole | 146 | $1,859 | $13 |
| Nadolol | 17 | $1,028 | $60 |
| Azathioprine | 24 | $788 | $33 |
| Pantoprazole | 64 | $707 | $11 |
| Peg 3350-Electrolyte | 33 | $491 | $15 |
2015: 10 drugs
| Apriso | 26 | $10,637 | $409 |
| Moviprep | 89 | $7,147 | $80 |
| Linzess | 25 | $7,094 | $284 |
| Mesalamine | 13 | $4,142 | $319 |
| Omeprazole | 186 | $2,031 | $11 |
| Nadolol | 20 | $1,429 | $71 |
| Pantoprazole | 73 | $1,021 | $14 |
| Azathioprine | 19 | $528 | $28 |
| Metronidazole | 12 | $182 | $15 |
| Spironolactone | 11 | $78 | $7 |
2014: 14 drugs
| Lialda | 11 | $10,411 | $946 |
| Moviprep | 63 | $4,878 | $77 |
| Apriso | 13 | $4,563 | $351 |
| Mesalamine | 11 | $3,395 | $309 |
| Dexilant | 15 | $2,804 | $187 |
| Omeprazole | 213 | $2,702 | $13 |
| Ursodiol | 12 | $2,268 | $189 |
| Pantoprazole | 106 | $1,690 | $16 |
| Clarithromycin | 12 | $580 | $48 |
| Prednisone | 13 | $168 | $13 |
| Sulfamethoxazole-Trimethoprim | 17 | $128 | $8 |
| Ranitidine | 12 | $98 | $8 |
| Amoxicillin | 12 | $76 | $6 |
| Amitriptyline | 12 | $52 | $4 |
2013: 12 drugs
| Budesonide Ec | 11 | $15,130 | $1,375 |
| Zegerid | 12 | $4,136 | $345 |
| Halflytely-Bisacodyl | 50 | $3,386 | $68 |
| Nexium | 14 | $3,345 | $239 |
| Omeprazole | 175 | $2,783 | $16 |
| Dexilant | 14 | $2,764 | $197 |
| Pantoprazole | 108 | $2,529 | $23 |
| Moviprep | 34 | $2,490 | $73 |
| Sulfamethoxazole-Trimethoprim | 19 | $170 | $9 |
| Azathioprine | 13 | $170 | $13 |
| Prednisone | 11 | $53 | $5 |
| Amitriptyline | 11 | $30 | $3 |
Professional record
- NPI
- 1578625828
- Licence
- CA A108150, PA MD421763California A108150: Current · expires 2028-08-31
- Trained
- Eastern Virginia Medical School, 2000
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 2440 Samaritan Dr, Suite #1, San Jose, CA, 95124
- NPI first listed
- 2006-12-14
- NPI last updated
- 2009-07-14
This is when the NPI record was last certified, not a medical board exam.